Skip to content

Medical-device intelligence

Terumo Cardiovascular Systems Corporation: FDA clearances and recalls

Research Terumo Cardiovascular Systems Corporation in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

29 clearance records and 358 recall records in the covered releases, across 1 source company names and 26 product codes. Dated history runs from Sep 19, 2002 to May 28, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

387 matching records
Device / recordCompany in FDA recordSourceSource date
Sarns flexible arterial cannula, 7.3 mm (22 Fr) OD with 3/8in connector, suture ring, 9.5in (24 cm) long The Sarns&a…Z-0667-2013 · DWFTerumo Cardiovascular Systems CorporationRecallJan 11, 2013FDA classification date
Sarns flexible arterial cannula, 8.0 mm (24 Fr) with 3/8in connector, suture ring, 9.5in (24 cm) long The Sarns&…Z-0668-2013 · DWFTerumo Cardiovascular Systems CorporationRecallJan 11, 2013FDA classification date
Sarns high-flow aortic arch cannula, 5.2 mm (16 Fr) OD with 3/8in connector, 7.5in (19 cm) long The Sarns&am…Z-0669-2013 · DWFTerumo Cardiovascular Systems CorporationRecallJan 11, 2013FDA classification date
Sarns high-flow aortic arch cannula, 6.5 mm (20 Fr) OD with 3/8in connector, 11in (28 cm) long The Sarns&amp…Z-0670-2013 · DWFTerumo Cardiovascular Systems CorporationRecallJan 11, 2013FDA classification date
Sarns high-flow aortic arch cannula, 6.5 mm (20 Fr) OD with 3/8in connector, 11in (28 cm) long, with X coating surface The Sarns&amp…Z-0671-2013 · DWFTerumo Cardiovascular Systems CorporationRecallJan 11, 2013FDA classification date
24 Fr 8mm Sft Flow Str Wire W/L The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass …Z-0456-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
24 Fr 8mm Sft Flow Straight Wir The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass …Z-0457-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
24 Fr 8mm Sft Flow Straight The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass surg…Z-0458-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
18 Fr 6mm Sft Flow Angled Wire The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass s…Z-0459-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
18 Fr 6mm Sft Flow Ang Wire W/L The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass …Z-0460-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
24 Fr 8mm Soft Flow Ang Wire W/L The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass…Z-0461-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
24 Fr 8mm Soft Flow Ang W/L The Sarns Aortic Cannula is indicated for use in perfusion of the ascending aorta during cardiopulmonary bypass surg…Z-0462-2013 · DWFTerumo Cardiovascular Systems CorporationRecallDec 3, 2012FDA classification date
100/120V AC, Advanced Perfusion System Platform (APS) The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extra…Z-0435-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 27, 2012FDA classification date
220/240V AC, Advanced Perfusion System Platform (APS) The Terumo Advanced Perfusion System 1 is indicated for use for up to 6 hours on the extra…Z-0436-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 27, 2012FDA classification date
HX2 Temp Manage SYS 120V The Terumo HX2 Temperature Management System is a selfcontained, dual channel system for supplying temperature controll…Z-0278-2013 · DWCTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Tested AC Control BD, 120V, X2 The Terumo HX2 Temperature Management System is a selfcontained, dual channel system for supplying temperature co…Z-0279-2013 · DWCTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 4 pump, 115V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 hours…Z-0280-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 5 pump, 115V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 hours…Z-0281-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 4 pump, 220V/240V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 …Z-0282-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 5 pump, 220V/240V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 …Z-0283-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 4 pump, 100V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 hours…Z-0284-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 5 pump, 100V safety monitor included The Sarns" Modular Perfusion System 8000 is indicated for use for up to 6 hours…Z-0285-2013 · DTQTerumo Cardiovascular Systems CorporationRecallNov 13, 2012FDA classification date
Perfusion System 8000, base 4 pump, 115V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hour…Z-0126-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date
Perfusion System 8000, base 5 pump, 115V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6 hour…Z-0127-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date
Perfusion System 8000, base 4 pump, 220V/240V safety monitor included The Sarns Modular Perfusion System 8000 is indicated for use for up to 6…Z-0128-2013 · DTQTerumo Cardiovascular Systems CorporationRecallOct 24, 2012FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗